Clinical News - Ophthalmology Times
Ophthalmology Times
Clinical News

FDA approves Sirion's NDA for ganciclovir 0.15% for herpetic keratitis

October 2, 2009

The FDA has approved a new drug application (NDA) for ganciclovir ophthalmic gel 0.15% (Zirgan, Sirion Therapeutics) as a treatment for acute herpetic keratitis (dendritic ulcers), the company announced.

World Sight Day set for Oct. 8

October 2, 2009

Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct. 8.

Presbia unveils implantable micro-lens

October 2, 2009

Presbia Coöperatief U.A. of Amsterdam unveiled an implantable micro-lens treatment (Flexivue System) for presbyopia at the European Society of Cataract and Refractive Surgeons annual meeting.

AMD Alliance International organizes video contest to raise awareness

October 2, 2009

AMD Alliance International is hosting a video contest to raise awareness for age-related macular degeneration (AMD). Individuals are invited to create and submit videos of no longer than 3 minutes that will communicate in the most creative and visually interesting ways the impact of AMD.

Allergan, Pieris AG agreement targets anticalin for treatment of ocular disorders

September 16, 2009

Pieris AG announced that it has entered into a collaboration agreement with Allergan Inc. that will combine Pieris' proprietary anticalin technology with Allergan's drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular disorders.

Ganciclovir ophthalmic gel 0.15% approved by FDA for herpetic keratitis

September 16, 2009

Sirion Therapeutics Inc. announced the FDA approval of its new drug application for ganciclovir ophthalmic gel 0.15% (Zirgan) as a treatment for acute herpetic keratitis. The FDA granted orphan drug designation to the gel for this indication in April 2007.

FDA approves bepotastine drops for ocular itching

September 16, 2009

The FDA has approved bepotastine besilate ophthalmic solution 1.5% (Bepreve, ISTA Pharmaceuticals) as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis.

ESCRS: Surgeon outlines technique, intraoperative findings, postoperative regimen

September 16, 2009

Surgeons should not use home-made solutions or riboflavin in their corneal cross-linking technique, as it leads to unreliable results, said Paolo Vinciguerra, MD.

ESCRS: Biomechanics of the crossed-link cornea explored

September 16, 2009

The next steps in the evolution of corneal cross linking (CXL) therapy must seek to improve the penetration of riboflavin to the deepest corneal layers, said Jesper Hjortdal, MD, PhD.

ADVERTISEMENT

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here



Click here